• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 3. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 4. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

2,6-Pyridinediamine, 4-methoxy-: A Comprehensive Overview

2,6-Pyridinediamine, 4-methoxy- is a synthetic organic compound that has garnered significant attention in the field of biomedical research. Known by its CAS Registry Number CAS NO 18960-98-0, this compound belongs to the family of pyridine derivatives and exhibits unique chemical properties that make it a valuable subject for scientific investigation. Its structure, characterized by two amine groups at positions 2 and 6 on a pyridine ring, with a methoxy group at position 4, renders it both structurally distinct and functionally versatile.

The compound's synthesis involves intricate organic reactions, often employing methods such as the Hoffmann-L?ffler reaction or other nitrogenation techniques. These processes highlight the importance of controlling reaction conditions to achieve high purity and yield, which are critical for its application in various biomedical contexts. Recent advancements in synthetic chemistry have further refined the methods used to prepare 2,6-Pyridinediamine, 4-methoxy-, enabling researchers to explore its potential more effectively.

In terms of chemical properties, this compound is notable for its ability to participate in various types of chemical reactions. Its amine groups facilitate nitrosation and other nitrogen-based transformations, while the methoxy group introduces steric and electronic effects that influence reactivity. These characteristics make it a valuable building block in the synthesis of more complex molecules, including those with potential pharmacological activity.

Biochemical applications of 2,6-Pyridinediamine, 4-methoxy- are diverse and expanding rapidly. One area of intense research is its role as a scaffold for the development of novel drugs. Its structural features allow it to serve as a platform for attaching bioactive groups, such as those with anticancer, anti-inflammatory, or neuroprotective properties. Recent studies have demonstrated its potential in targeting specific pathways involved in diseases like cancer and neurodegenerative disorders.

Another promising application lies in the field of molecular imaging. The compound's ability to coordinate with metal ions makes it a candidate for use in contrast agents or as a chelating agent in nuclear medicine. For instance, research has explored its use in enhancing the efficacy of MRI contrast agents, potentially improving diagnostic accuracy in various medical conditions.

The safety and toxicity profile of 2,6-Pyridinediamine, 4-methoxy- have been studied extensively. While it exhibits some cytotoxicity at high concentrations, its biocompatibility at lower doses suggests that it could be safely used in certain biomedical applications. Ongoing research focuses on optimizing its dosage and delivery methods to maximize therapeutic benefits while minimizing adverse effects.

Recent advancements in drug delivery systems have further enhanced the potential of this compound. Its ability to form complexes with other molecules makes it a suitable candidate for use in nanoformulations. For example, researchers have explored its use in creating liposomal formulations or dendrimer-based delivery systems, which can improve the targeting and efficacy of drugs.

In conclusion, 2,6-Pyridinediamine, 4-methoxy- (CAS NO 18960-98-0) stands out as a compound with significant potential in various biomedical applications. Its unique structure, combined with its ability to participate in diverse chemical reactions, positions it as a valuable tool for researchers in the fields of pharmacology, molecular imaging, and nanomedicine. As scientific understanding of this compound continues to evolve, its role in advancing biomedical research is expected to grow even further.

• 10201-73-7(4-methoxypyridin-2-amine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)